Rigel Pharmaceuticals
RIGL
#7112
Rank
A$0.78 B
Marketcap
A$42.60
Share price
0.50%
Change (1 day)
27.08%
Change (1 year)

EPS for Rigel Pharmaceuticals (RIGL)

EPS in 2025 (TTM): A$9.73

According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is A$8.96. In 2024 the company made an earnings per share (EPS) of A$1.40.

EPS history for Rigel Pharmaceuticals from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$9.73594.31%
2024A$1.40
2022A-$4.82240%
2021A-$1.42-37.5%
2020A-$2.27-60%
2019A-$5.66-11.11%
2018A-$6.37-26.23%
2017A-$8.64-17.57%
2016A-$10.4825.42%
2015A-$8.36-42.72%
2014A-$14.59
2012A-$18.84

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
A$20.51 128.75%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$9.84 9.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sangamo Therapeutics
SGMO
A-$0.62-106.95%๐Ÿ‡บ๐Ÿ‡ธ USA
ChemoCentryx
CCXI.defunct
A-$2.68-129.86%๐Ÿ‡บ๐Ÿ‡ธ USA